KROS Chart
See on advanced chart >
About
Keros Therapeutics, Inc. was originally incorporated under the laws of the State of Delaware in December 2015.The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for...
Read More
- HighlightA clinical-stage biopharmaceutical company that developing products for hematological and musculoskeletal disorders
- ExchangeNASDAQ
- Listing Date04/08/2020
- Established DateInvalid Date
- Full-time Employees136
- Address1050 Waltham Street Suite 302 02421 Lexington Massachusetts
- Tel1-617-3146297
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology